Q1 2026 Holdings
Filed 2026-05-15 | 41 holdings | $3.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $458.3M | 5,502,710 | 14.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $298.3M | 16,001,284 | 9.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $277.8M | 2,856,782 | 8.9% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $184.2M | 2,559,595 | 5.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $166.7M | 3,459,358 | 5.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $146.4M | 1,584,727 | 4.7% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $121.6M | 8,650,158 | 3.9% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $119.8M | 960,989 | 3.8% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $93.5M | 3,734,142 | 3.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $86.0M | 7,133,720 | 2.7% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $82.9M | 2,547,557 | 2.6% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $81.7M | 5,750,683 | 2.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $81.4M | 1,272,312 | 2.6% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $81.3M | 2,590,303 | 2.6% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $79.0M | 5,295,893 | 2.5% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $75.7M | 1,976,196 | 2.4% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $73.4M | 4,460,886 | 2.3% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $70.7M | 2,000,000 | 2.3% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $68.7M | 8,445,769 | 2.2% |
| AC Immune SA(ACIU) | SHS | H00263105 | $54.5M | 19,822,436 | 1.7% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $50.5M | 2,748,763 | 1.6% |
| Annexon Inc(ANNX) | COM | 03589W102 | $48.2M | 8,698,173 | 1.5% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $41.1M | 7,764,842 | 1.3% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $39.0M | 1,294,463 | 1.2% |
| Septerna Inc(SEPN) | COM | 81734D104 | $32.5M | 1,353,249 | 1.0% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $31.2M | 1,251,788 | 1.0% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $27.9M | 5,842,000 | 0.9% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $26.8M | 2,879,289 | 0.9% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $25.4M | 19,525,000 | 0.8% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $24.4M | 1,632,845 | 0.8% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $19.4M | 6,293,282 | 0.6% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $16.7M | 3,000,000 | 0.5% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $9.2M | 2,233,742 | 0.3% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $8.5M | 7,652,972 | 0.3% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $8.2M | 1,978,972 | 0.3% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $5.6M | 5,564,290 | 0.2% |
| Imagenebio Inc(IMA) | COM | 45175G207 | $5.6M | 1,110,002 | 0.2% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $5.4M | 339,549 | 0.2% |
| Molecular Partners AG(MOLN) | ADS | 60853G106 | $5.4M | 1,353,968 | 0.2% |
| Inventiva SA(IVA) | ADS | 46124U107 | $3.8M | 686,040 | 0.1% |
| Engene Holdings Inc(ENGNW) | *W EXP 10/31/202 | 29286M113 | $2.5M | 945,402 | 0.1% |